SCHEMBL5038424

SCHEMBL5038424

NCCSc1nnc(N)s1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
FBP1 P09467 1/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
NPC1 O15118 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15362563 0.89 ALDH1A1 (0.68) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL11228856 0.88 ALDH1A1 (0.66) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL30905074 0.81 ALDH1A1 (0.59) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL30106089 0.81 ALDH1A1 (0.59) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL8479039 0.81 ALDH1A1 (0.73) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL10974071 0.78 ALDH1A1 (0.69) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL12892266 0.77 PTGS2 (0.43) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL30905061 0.76 NPC1 (0.59) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL11659835 0.76 ALDH1A1 (0.58) ALDH1A1FBP1MEN1KMT2ATDP1
SCHEMBL2454347 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1450796-B1 BENZOTHIAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
US-6596718-B1 A compound of formula I has a good affinity to the A2A receptor and is useful for the treatment of diseases mediated by this receptor. HOFFMANN-LA ROCHE INC. 2003-07-22 US disclosed